Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Depression, immunity, and survival in patients with hepatobiliary carcinoma.

Depression, immunity, and survival in patients with hepatobiliary carcinoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Depression, immunity, and survival in patients with hepatobiliary carcinoma. Abstract Text:

    james c coyneJames C Coyne,steven c palmerSteven C Palmer,james c coyneJames C Coyne,steven c palmerSteven C Palmer,

    PURPOSE: The aims of the present study were to assess the prevalence of depressive symptoms at diagnosis, test the association between depressive symptoms and survival, and preliminarily test a mediational model of depression, immunity, and survival in patients with hepatobiliary carcinoma (HBC). PATIENTS AND METHODS: One hundred one patients diagnosed with HBC were prospectively studied. Depressive symptoms were measured at diagnosis using the Center for Epidemiological Studies Depression Scale (CES-D). Sociodemographic and disease-specific data were gathered from the patients' charts. In a subsample of patients, stress; alcohol, tobacco, and drug use; sleep quality; physical activity; social support; natural killer (NK) cell number and cytotoxicity; and plasma levels of interleukin (IL) -4, IL-5, tumor necrosis factor alpha, and interferon gamma were measured. Survival was measured from date of diagnosis to death. RESULTS: At diagnosis, 37% of patients reported a CES-D score of > or = 16 (clinical range). Using Cox regression analysis, sociodemographic and disease-specific variables and CES-D score significantly predicted survival (Breslow chi2 = 32.4, P = .006). Only vascular invasion (P = .001) and CES-D score > or = 16 (P = .03) were significant predictors. In a subsample of 23 patients, patients who reported a CES-D score of > or = 16 were found to have significantly lower NK cell numbers than patients who reported a CES-D score of less than 16 (F1,21 = 9.39, P = .003). A robust trend was found in which NK cell number was associated with survival. A mediational model linking depressive symptoms and survival, with NK cell number as a mediator, was preliminarily supported. CONCLUSION: Secondary to the high prevalence of depressive symptoms and impact on survival, psychological and pharmacologic interventions should be designed and implemented in patients diagnosed with HBC.

    Depression, immunity, and survival in patients with hepatobiliary carcinoma. Publishing Authors By Initials

    jc coyneJC Coyne,sc palmerSC Palmer,jc coyneJC Coyne,sc palmerSC Palmer,

    For similar investigative techniques: epidemiologic methods: statistics as topic: survival analysis research abstracts see: investigative techniques: epidemiologic methods: statistics as topic: survival analysis research

    PUBMED ID PMID:

    MEDLINE DATE:

    Depression, immunity, and survival in patients with hepatobiliary carcinoma. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Journal of clinical oncology : official journal of

    VOLUME: 25

    Page Numbers: 2397-405

    Journal Abbreviation: J. Clin. Oncol.

    ISSN: 1527-7755

    DAY: 10

    MONTH: Jun

    YEAR: 2007

    Depression, immunity, and survival in patients with hepatobiliary carcinoma. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8309333

    Depression, immunity, and survival in patients with hepatobiliary carcinoma. Keywords Mesh Terms:

    KEYWORDS: Survival Analysis

    MESH TERMS: psychology

    Chemical & Substance for Abstract: Depression, immunity, and survival in patients with hepatobiliary carcinoma. Information

    Substance Name: Cytokines

    Registry Number: 0

    Grant and Affiliation Information for Depression, immunity, and survival in patients with hepatobiliary carcinoma.

    AFFILIATION: University of Pittsburgh School of Medicine, Liver Cancer Center, Department of Surgery, Starzl Transplantation Institute, Pittsburgh, PA 15213, USA. steeljl@msx.upmc.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NHLBI

    GRANT: HL076858

    ACRONYM: HL

    MEDLINETA: J Clin Oncol

    REFSOURCE: J Clin Oncol. 2007 Nov 20;25(33):5328-9;

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Depression, immunity, and survival in patients with hepatobiliary carcinoma Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News